Skip to main content
. 2013 Sep 30;31(3):131–137. doi: 10.3857/roj.2013.31.3.131

Table 4.

Prognostic factors for LRC, DMFS, and PFS in patients with Masaoka stage III

graphic file with name roj-31-131-i004.jpg

LRC, locoregional control; DMFS, distant metastasis-free survival; PFS, progression-free survival; UNI, univariate analysis; MULTI, multivariate analysis; ECOG PS, Eastern Cooperative Oncology Group performance status.